PER 4.65% 9.0¢ percheron therapeutics limited

SAM..from the ANP announcement a week ago... The Company’s IND...

  1. 13,271 Posts.
    lightbulb Created with Sketch. 1412
    SAM..from the ANP announcement a week ago...

    The Company’s IND application for a Phase IIb trial in 195 MS patients is on track for submission to the US Food and Drug Administration (FDA) by April 2017. Monkey plasma samples from a previously conducted animal toxicology study have been assayed and the pharmacokinetic data will soon be available for inclusion in the IND application. Following the IND submission, the Company must wait 30 calendar days for the FDA to review the submission.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢
Change
0.004(4.65%)
Mkt cap ! $81.13M
Open High Low Value Volume
8.6¢ 9.1¢ 8.5¢ $181.6K 2.049M

Buyers (Bids)

No. Vol. Price($)
1 10344 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 64275 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.